Market News

Breaking headlines and analysis across every asset class.

Markets
AD HOC NEWS • Sep 1, 2026
Albemarle stock holds steady as Chilean strike vote and 2026 lithium guidance shape outlook

Albemarle stock is holding steady despite a potential strike by workers in Chile, which could impact its global lithium supply. The company's 2026 lithium production guidance for its Atacama operations is 70,700 tons LCE, below its nominal capacity, while global lithium demand grew 45% through May 2026. The article discusses mixed valuation signals, labor risks, and the company's diversified portfolio including clear brine fluids.

Markets
AD HOC NEWS • Sep 1, 2026
Evergy stock holds steady as utility volatility cools into late August

Evergy stock has remained stable through late August 2026, even as volatility in the broader utility sector has decreased. This stability underscores Evergy's appeal as a reliable income-generating investment within the S&P 500 utilities, with institutional funds maintaining significant holdings. The company's business model focuses on regulated power services, positioning it as a defensive holding for income-focused investors.

Markets
GuruFocus • Sep 1, 2026
Cboe Global Markets Inc (CBOE) Shares Fall 3.3% -- GF Value Says Still Overvalued

Cboe Global Markets Inc (CBOE) shares dropped 3.3% to $300.20, yet GuruFocus's GF Value still assesses the stock as 31.7% overvalued compared to its intrinsic value estimate of $227.98. Despite a strong GF Score of 92/100, indicating robust fundamentals, the high valuation and insider selling suggest caution for potential investors. The company's P/E ratio is below its historical median, but this does not offset the overall overvaluation.

Markets
Simply Wall Street • Sep 1, 2026
Is Charles River Laboratories International (CRL) Cheap After Its Medigen Vaccine Partnership?

Charles River Laboratories International (CRL) has drawn attention due to its recent partnership with Medigen Vaccine Biologics for next-generation vaccine work, utilizing its biologics testing and Next-Generation Sequencing platforms. While the company has seen a strong share price surge recently (64.91% in 90 days, 76.50% in 1 year), its 5-year return is down 35.88%. The most followed narrative values CRL at $313.61 per share, suggesting it is 8.1% undervalued compared to its recent close of $

Earnings
The Motley Fool • Sep 1, 2026
Vistra CEO James Burke Buys 2,000 Shares After 29% Stock Decline

Vistra Corp. CEO James Burke indirectly purchased 2,000 shares of the company's stock for $270,000 on August 24, 2026, after the stock experienced a 29% decline over the preceding 12 months. This transaction, executed through JAMEB, LP, increases his total beneficial interest to approximately 1.2 million shares, valued at $167.63 million. Burke's purchase signals strong executive confidence in Vistra's valuation, especially after a Q2 earnings report that saw a stock sell-off due to an unrealize

Markets
Kalkine Media • Sep 1, 2026
Why Is Southern Company Getting Attention?

Southern Company (NYSE:SO) is currently gaining market attention due to its recent operating update on regulated utility priorities. As an electric and gas utility company, its communication regarding operational efforts and strategic direction is significant for market participants. The update provides qualitative signals about the company's focus and execution in the context of broader industry themes like customer selectivity and changing demand patterns.

Markets
Yahoo Finance • Sep 1, 2026
Jim Cramer Tells Mad Money Caller Why Netflix (NFLX) Is Worth a Moderate Buy

Jim Cramer advised a "moderate buy" on Netflix (NFLX) despite recent leadership missteps, including a botched buyout attempt and Reed Hastings stepping down. He acknowledged market anxiety about capital allocation but highlighted Netflix's strong financial results, with $12.56 billion in Q2 revenue and ambitious plans for $3 billion in advertising revenue by 2026. While institutional backing slightly decreased, Cramer believes the company's content execution can offset strategic issues, making i

Markets
Kalkine Media • Sep 1, 2026
Why Does News Corp's (ASX:NWS) Repurchase Program Exclude ASX Holders?

News Corporation (ASX:NWS) has clarified that its share repurchase program applies exclusively to its Nasdaq-listed shares, explicitly excluding Australian holders of Chess Depository Interests (CDIs) from participating. This distinction is crucial for local investors, highlighting the unique cross-market structure of the global media group. The disclosure emphasizes that corporate actions like this repurchase can be tailored to the primary listing, even for companies with a broad international

Markets
MarketBeat • Sep 1, 2026
Edwards Lifesciences (NYSE:EW) SVP Sells 544 Shares of Stock

Andrew Dahl, SVP of Edwards Lifesciences (NYSE:EW), sold 544 shares of the company's stock for approximately $49,537, reducing his stake by 3.53%. This insider sale comes as Edwards Lifesciences reported strong quarterly earnings, beating EPS estimates by $0.04 and seeing revenue increase by 13.6% year-over-year. Analysts currently hold a "Moderate Buy" consensus rating for the stock, with an average price target of $100.27.

Get Headlines in Your Inbox

One email a day with the market-moving stories you actually need to read.